Blinatumomab Expanded T-cells (BET) in Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia
Clinical trial NCT03823365 · UNKNOWN
Trial details
- NCT number
- NCT03823365
- Sponsor
- A.O. Ospedale Papa Giovanni XXIII
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-17
- Primary completion
- 2021-11-11
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.